In this interview, NewsMedical speaks with Kevin Jan from Yokogawa about the future of live cell imaging technologies.
EirGenix and Sandoz win EU approval for Herceptin biosimilar
Share this article Herceptin is a monoclonal antibody that binds to HER2 receptors, thereby, priming these receptors for immune system targeting. Image Credit: Cineberg /